Paul Mahon A.'s most recent trade in United Therapeutics Corp was a trade of 11,000 Common Stock done at an average price of $135.4 . Disclosure was reported to the exchange on Nov. 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 26 Nov 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 11,000 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 487.21 per share. | 26 Nov 2025 | 3,350 | 38,058 (0%) | 0% | 487.2 | 1,632,145 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 485.15 per share. | 26 Nov 2025 | 2,210 | 43,331 (0%) | 0% | 485.2 | 1,072,182 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 486.23 per share. | 26 Nov 2025 | 1,923 | 41,408 (0%) | 0% | 486.2 | 935,020 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 484.20 per share. | 26 Nov 2025 | 1,727 | 45,541 (0%) | 0% | 484.2 | 836,207 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 488.13 per share. | 26 Nov 2025 | 1,277 | 36,781 (0%) | 0% | 488.1 | 623,344 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 483.05 per share. | 26 Nov 2025 | 513 | 47,268 (0%) | 0% | 483.0 | 247,803 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 13 Nov 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2025 | 11,000 | 11,000 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 468.48 per share. | 13 Nov 2025 | 2,070 | 36,798 (0%) | 0% | 468.5 | 969,744 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 467.37 per share. | 13 Nov 2025 | 1,992 | 38,868 (0%) | 0% | 467.4 | 930,992 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 464.19 per share. | 13 Nov 2025 | 1,979 | 42,520 (0%) | 0% | 464.2 | 918,637 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 458.16 per share. | 13 Nov 2025 | 1,063 | 46,518 (0%) | 0% | 458.2 | 487,024 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 461.36 per share. | 13 Nov 2025 | 1,040 | 45,478 (0%) | 0% | 461.4 | 479,819 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 463.32 per share. | 13 Nov 2025 | 979 | 44,499 (0%) | 0% | 463.3 | 453,590 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 466.24 per share. | 13 Nov 2025 | 884 | 40,860 (0%) | 0% | 466.2 | 412,153 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 465.36 per share. | 13 Nov 2025 | 776 | 41,744 (0%) | 0% | 465.4 | 361,123 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 456.39 per share. | 13 Nov 2025 | 200 | 47,581 (0%) | 0% | 456.4 | 91,278 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 469.12 per share. | 13 Nov 2025 | 17 | 36,781 (0%) | 0% | 469.1 | 7,975 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 30 Oct 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 11,000 | 22,000 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 449.46 per share. | 30 Oct 2025 | 3,441 | 42,555 (0%) | 0% | 449.5 | 1,546,606 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 450.64 per share. | 30 Oct 2025 | 2,247 | 40,308 (0%) | 0% | 450.6 | 1,012,579 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 451.57 per share. | 30 Oct 2025 | 1,849 | 38,459 (0%) | 0% | 451.6 | 834,952 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 452.33 per share. | 30 Oct 2025 | 1,285 | 37,174 (0%) | 0% | 452.3 | 581,243 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 448.56 per share. | 30 Oct 2025 | 1,143 | 45,996 (0%) | 0% | 448.6 | 512,706 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 447.34 per share. | 30 Oct 2025 | 642 | 47,139 (0%) | 0% | 447.3 | 287,195 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 454.15 per share. | 30 Oct 2025 | 393 | 36,781 (0%) | 0% | 454.1 | 178,480 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 16 Oct 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2025 | 11,000 | 33,000 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 431.72 per share. | 16 Oct 2025 | 2,516 | 41,310 (0%) | 0% | 431.7 | 1,086,199 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 432.59 per share. | 16 Oct 2025 | 2,078 | 39,232 (0%) | 0% | 432.6 | 898,920 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 428.51 per share. | 16 Oct 2025 | 1,908 | 45,873 (0%) | 0% | 428.5 | 817,595 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 433.45 per share. | 16 Oct 2025 | 1,652 | 37,580 (0%) | 0% | 433.5 | 716,061 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 429.61 per share. | 16 Oct 2025 | 1,092 | 44,781 (0%) | 0% | 429.6 | 469,136 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 430.59 per share. | 16 Oct 2025 | 955 | 43,826 (0%) | 0% | 430.6 | 411,212 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 434.76 per share. | 16 Oct 2025 | 798 | 36,782 (0%) | 0% | 434.8 | 346,937 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 435.00 per share. | 16 Oct 2025 | 1 | 36,781 (0%) | 0% | 435 | 435 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2025 | 11,000 | 44,000 | - | - | Stock Option | |
| United Therapeutics Corp | A. Paul Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 02 Oct 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul Mahon A. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 437.15 per share. | 02 Oct 2025 | 3,136 | 39,506 (0%) | 0% | 437.2 | 1,370,905 | Common Stock |
| United Therapeutics Corp | A. Paul Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 438.17 per share. | 02 Oct 2025 | 1,905 | 37,601 (0%) | 0% | 438.2 | 834,710 | Common Stock |
| United Therapeutics Corp | Mahon Paul A. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 436.24 per share. | 02 Oct 2025 | 1,881 | 42,642 (0%) | 0% | 436.2 | 820,566 | Common Stock |
| United Therapeutics Corp | A. Paul Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 435.22 per share. | 02 Oct 2025 | 1,828 | 44,523 (0%) | 0% | 435.2 | 795,574 | Common Stock |
| United Therapeutics Corp | Mahon Paul A. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 433.72 per share. | 02 Oct 2025 | 1,430 | 46,351 (0%) | 0% | 433.7 | 620,224 | Common Stock |
| United Therapeutics Corp | Mahon A. Paul | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 440.16 per share. | 02 Oct 2025 | 474 | 36,781 (0%) | 0% | 440.2 | 208,636 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 439.19 per share. | 02 Oct 2025 | 346 | 37,255 (0%) | 0% | 439.2 | 151,959 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2025 | 11,000 | 55,000 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 18 Sep 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 406.39 per share. | 18 Sep 2025 | 3,222 | 40,086 (0%) | 0% | 406.4 | 1,309,394 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 405.45 per share. | 18 Sep 2025 | 2,973 | 43,308 (0%) | 0% | 405.5 | 1,205,403 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 407.42 per share. | 18 Sep 2025 | 2,105 | 37,981 (0%) | 0% | 407.4 | 857,613 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 408.11 per share. | 18 Sep 2025 | 1,200 | 36,781 (0%) | 0% | 408.1 | 489,737 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 404.33 per share. | 18 Sep 2025 | 1,100 | 46,281 (0%) | 0% | 404.3 | 444,760 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 402.50 per share. | 18 Sep 2025 | 400 | 47,381 (0%) | 0% | 402.5 | 161,000 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 04 Sep 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2025 | 11,000 | 66,000 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 381.58 per share. | 04 Sep 2025 | 2,335 | 43,681 (0%) | 0% | 381.6 | 890,997 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 389.16 per share. | 04 Sep 2025 | 1,800 | 37,479 (0%) | 0% | 389.2 | 700,485 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 386.51 per share. | 04 Sep 2025 | 1,499 | 41,257 (0%) | 0% | 386.5 | 579,380 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 380.62 per share. | 04 Sep 2025 | 1,266 | 46,016 (0%) | 0% | 380.6 | 481,867 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 387.41 per share. | 04 Sep 2025 | 1,128 | 40,129 (0%) | 0% | 387.4 | 436,996 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 387.86 per share. | 04 Sep 2025 | 850 | 39,279 (0%) | 0% | 387.9 | 329,683 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 379.47 per share. | 04 Sep 2025 | 499 | 47,282 (0%) | 0% | 379.5 | 189,357 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 390.46 per share. | 04 Sep 2025 | 400 | 37,079 (0%) | 0% | 390.5 | 156,185 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 382.21 per share. | 04 Sep 2025 | 350 | 43,331 (0%) | 0% | 382.2 | 133,773 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 383.28 per share. | 04 Sep 2025 | 300 | 43,031 (0%) | 0% | 383.3 | 114,983 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 384.90 per share. | 04 Sep 2025 | 275 | 42,756 (0%) | 0% | 384.9 | 105,848 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 396.54 per share. | 04 Sep 2025 | 200 | 36,781 (0%) | 0% | 396.5 | 79,308 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 392.03 per share. | 04 Sep 2025 | 98 | 36,981 (0%) | 0% | 392.0 | 38,419 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2025 | 11,000 | 77,000 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 21 Aug 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 309.43 per share. | 21 Aug 2025 | 4,234 | 38,876 (0%) | 0% | 309.4 | 1,310,122 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 308.43 per share. | 21 Aug 2025 | 2,330 | 43,110 (0%) | 0% | 308.4 | 718,637 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 310.25 per share. | 21 Aug 2025 | 2,095 | 36,781 (0%) | 0% | 310.2 | 649,971 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 307.39 per share. | 21 Aug 2025 | 1,441 | 45,440 (0%) | 0% | 307.4 | 442,943 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 304.56 per share. | 21 Aug 2025 | 600 | 47,181 (0%) | 0% | 304.6 | 182,739 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 306.12 per share. | 21 Aug 2025 | 300 | 46,881 (0%) | 0% | 306.1 | 91,837 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 07 Aug 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2025 | 11,000 | 88,000 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 299.48 per share. | 07 Aug 2025 | 2,918 | 42,119 (0%) | 0% | 299.5 | 873,889 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 300.47 per share. | 07 Aug 2025 | 2,837 | 39,282 (0%) | 0% | 300.5 | 852,424 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 301.67 per share. | 07 Aug 2025 | 1,401 | 37,881 (0%) | 0% | 301.7 | 422,634 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 297.49 per share. | 07 Aug 2025 | 1,391 | 46,390 (0%) | 0% | 297.5 | 413,812 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 298.73 per share. | 07 Aug 2025 | 1,353 | 45,037 (0%) | 0% | 298.7 | 404,179 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 302.70 per share. | 07 Aug 2025 | 1,000 | 36,881 (0%) | 0% | 302.7 | 302,697 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 303.45 per share. | 07 Aug 2025 | 100 | 36,781 (0%) | 0% | 303.5 | 30,345 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 24 Jul 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2025 | 11,000 | 99,000 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 304.25 per share. | 24 Jul 2025 | 4,977 | 39,035 (0%) | 0% | 304.3 | 1,514,268 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 303.31 per share. | 24 Jul 2025 | 3,769 | 44,012 (0%) | 0% | 303.3 | 1,143,161 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 305.14 per share. | 24 Jul 2025 | 2,254 | 36,781 (0%) | 0% | 305.1 | 687,795 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 10 Jul 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 11,000 | 110,000 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 300.48 per share. | 10 Jul 2025 | 7,738 | 38,139 (0%) | 0% | 300.5 | 2,325,108 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 301.20 per share. | 10 Jul 2025 | 1,358 | 36,781 (0%) | 0% | 301.2 | 409,023 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 299.49 per share. | 10 Jul 2025 | 1,304 | 45,877 (0%) | 0% | 299.5 | 390,530 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 297.89 per share. | 10 Jul 2025 | 600 | 47,181 (0%) | 0% | 297.9 | 178,732 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 26 Jun 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2025 | 11,000 | 121,000 | - | - | Stock Option |